Health Condition 1: C910- Acute lymphoblastic leukemia [ALL] Health Condition 2: C921- Chronic myeloid leukemia, BCR/ABL-positive Health Condition 3: I10- Essential (primary) hypertension Health Condition 4: C50- Malignant neoplasm of breast Health Condition 5: C34- Malignant neoplasm of bronchus andlung Health Condition 6: C15-C26- Malignant neoplasms of digestive organs Health Condition 7: E11- Type 2 diabetes mellitus
Conditions
Interventions
Intervention1: Smart phone application based reminders: In the intervention group, patients with diabetes mellitus/ hypertension/ cancer on antidiabetic/ antihypertensive/ oral anticancer drugs will r
Sponsors
JIPMER Puducherry
Eligibility
Inclusion criteria
Inclusion criteria: Diabetes mellitus and Systemic hypertension: 1. Patients with type 2 diabetes (T2DM) aged greater than 18years irrespective of gender, who are on stable dose of anti-diabetic medication for at least 1 month 2. Patients with Systemic hypertension aged greater than 18years irrespective of gender, who are on stable dose of antihypertensive medication for at least 1 month 3. Patients with concomitant type 2 diabetes and systemic hypertension 4. Patients who are able to read Tamil/ English/ Hindi 5. Patients who are owning and operating a smartphone at least for 3 months 6. Patients who are using the smartphone daily, having the phone within reach and checking it atleast three times a day 7. Patients who have not used any medication adherence application till now Cancer: 8. Patients with gastro-intestinal malignancies receiving capecitabine 9. Patients with chronic myeloid leukemia receiving imatinib 10. Patients with breast cancer receiving hormonal therapy (tamoxifen) 11. Patients with lung cancer receiving gefitinib 12. Patients with Acute lymphoid leukemia receiving methotrexate/ 6-mercaptopurine 13. Patients who are able to read Tamil/ English/ Hindi 14. Patients who are owning and operating a smartphone for at least 3 months 15. Patients who are using the smartphone daily, having the phone within reach and checking it atleast three times a day 16. Patients who have not used any medication adherence application till now
Exclusion criteria
Exclusion criteria: Diabetes mellitus and Systemic hypertension: 1. Diabetic patients on insulin therapy 2. Patients with secondary hypertension or gestational hypertension 3. Patients with hypertensive emergency/ urgency 4. Pregnant or lactating women 5. Patients with hepatic/ renal impairment 6. Patients with h/o Coronary artery disease, cerebrovascular disease, stroke, Myocardial Infarction(MI) in the past 3 months 7. Patients who had participated in any other trials in the past 3 months 8. Patients with h/o surgery in the past 3 months or planning for surgery in the next 3 months 9. Patients on herbal medications Cancer: 10. Pregnant or lactating women 11. Patients with h/o surgery in the past 3 months or planning for surgery in the next 3 months 12. Patients with hepatic/ renal impairment 13. Patients with h/o Coronary artery disease, cerebrovascular disease, stroke, MI in the past 3 months 14. Patients who had participated in any other trials in the past 3 months 15. Patients on herbal medications
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Adherence to medication (measured using pill count and Medication Adherence Rating Scale(MARS) /Morisky Medication Adherence Scale-8(MMAS-8)) in patients with chronic diseases (Diabetes Mellitus/ Hypertension/ Cancer)Timepoint: After 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Diabetes mellitus / Systemic hypertension: To determine the Changes in HbA1c levels in diabetes patients Changes in systolic and diastolic BP values in hypertension patients Changes in HbA1c levels, systolic and diastolic BP values in patients with concomitant diabetes and hypertension Changes in lipid profile in patients with concomitant dyslipidemia Cancer: Disease progression/ occurrence of metastasis/ recurrence of tumor in intervention and control group. Timepoint: 3 months | — |
Countries
India
Contacts
Public ContactDr S Kalaimani
Jawaharlal Institute of Postgraduate Medical Education & Research
Outcome results
None listed